Literature DB >> 7264300

Human IgE antibody synthesis in vitro: stimulation of IgE responses by pokeweed mitogen and selective inhibition of such responses by human suppressive factor of allergy (SFA).

B L Zuraw, M Nonaka, C O'Hair, D H Katz.   

Abstract

The studies presented herein provide details of an in vitro system in which IgE biosynthesis by human peripheral mononuclear cells can be stimulated by exposure to pokeweed mitogen (PWM). Mononuclear cells of normal donors or patients with hyperimmunoglobulinemia E were cultured in 2 stages, the first stage consisting of exposure of cells to stimulating mitogen; after this first stage incubation, cells were washed and replated in cultures devoid of any additional mitogen for a further 6 days. Under such conditions, human mononuclear cells were shown to synthesize significant quantities of IgE. Both T cells and surface IgE-bearing cells were shown to be necessary in order to obtain an IgE response in this system. Supernatants from 2-way human mixed lymphocyte cultures were shown to contain an IgE class-specific suppressive factor capable of selectively inhibiting in vitro IgE (and not IgG) biosynthesis. This model can be used to compare the regulation of IgE synthesis in normal and atopic donors, and further experiments examining the production and action of this class-specific suppressive factor may have prognostic and therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7264300

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Comparison of IgE expression at the mRNA and protein levels in vitro.

Authors:  K J Turner; J Creany; R J Coelen; K J Cameron; B J Holt; M W Beilharz
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

Review 2.  Genetic control of IgE immune response.

Authors:  S Matsushita; T Sasazuki
Journal:  Clin Rev Allergy       Date:  1989

3.  Suppression of IgE synthesis in vitro by allogeneic T cells from atopic and non-atopic subjects.

Authors:  J J Zaunders; D A Cooper; Y Young; M Duckett; R Penny; J B Ziegler
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

Review 4.  Control of IgE synthesis in man.

Authors:  D Y Leung; R S Geha
Journal:  J Clin Immunol       Date:  1986-07       Impact factor: 8.317

5.  Expression of a biologically active fragment of human IgE epsilon chain in Escherichia coli.

Authors:  F T Liu; K A Albrandt; C G Bry; T Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

6.  In vitro synthesis of IgE by human lymphocytes. I. The spontaneous secretion of IgE by B lymphocytes from allergic individuals: a model to investigate the regulation of human IgE synthesis.

Authors:  M Sarfati; M Rubio-Trujillo; K Wong; E Rector; A H Sehon; G Delespesse
Journal:  Immunology       Date:  1984-10       Impact factor: 7.397

7.  Anti-IgE autoantibody in patients with bronchial asthma.

Authors:  Y Nawata; T Koike; T Yanagisawa; I Iwamoto; T Itaya; S Yoshida; H Tomioka
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

8.  Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma.

Authors:  C L King; J I Gallin; H L Malech; S L Abramson; T B Nutman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Increased expression of the IgE Fc receptors on rat macrophages induced by elevated serum IgE levels.

Authors:  G Boltz-Nitulescu; J M Plummer; H L Spiegelberg
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

10.  Functional heterogeneity of human T cell clones from atopic and non-atopic donors.

Authors:  C A Chambers; B Zimmerman; N Hozumi
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.